Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) were up 12.1% on Thursday . The company traded as high as C$0.19 and last traded at C$0.19. Approximately 109,894 shares changed hands during mid-day trading, a decline of 79% from the average daily volume of 527,897 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Stock Performance
The company has a market cap of C$25.10 million, a price-to-earnings ratio of -18.00 and a beta of 0.32. The firm’s 50 day simple moving average is C$0.11 and its 200-day simple moving average is C$0.08. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- What is the Hang Seng index?
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
- Transportation Stocks Investing
- MarketBeat Week in Review – 01/27 – 01/31
- What is a Death Cross in Stocks?
- Trump 2.0: This Sector May See A Big Performance Boost
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
